LAKE FOREST, Calif.--()--Tenex Health announces the appointment of Tommy G. Thompson to its Board of Directors. Tommy G. Thompson is a former United States Health and Human Services (HHS) Secretary and four-term Governor of Wisconsin. Following his term in public office, he built on his efforts as HHS Secretary and Governor to develop innovative solutions to the health care challenges facing American families, businesses, communities, states and the nation as a whole. These efforts focus on improving the use of information technology in hospitals, clinics and doctors’ offices, promoting healthier lifestyles, strengthening and modernizing Medicare and Medicaid, and expanding the use of medical diplomacy around the world.
“Tenex Health has created an innovative solution for chronic joint pain that addresses all of the core challenges facing our health care system: a safe procedure, effective and sustainable results, quick recovery and rapid return to activity for patients, and cost-effectiveness. The company is well positioned for explosive growth and I look forward to working side by side with them to expand the use and applications of their ground-breaking technology to a large and growing patient population both within the US and abroad,” commented Governor Thompson.
Since leaving public office, Governor Thompson has served as a senior advisor at the consulting firm Deloitte and Touche USA LLP and was the founding independent chairman of the Deloitte Center for Health Solutions, which researches and develops solutions to some of our nation’s most pressing health care and public health related challenges. Governor Thompson has also served as the President and separately Chairman of the Board of Directors of Logistics Health. He currently serves on the Board of Directors of the following public companies: CareView Communications, Inc., Chairman of the Board of Directors, Centene Corporation, C.R. Bard, Inc., United Therapeutics Corporation, Cytori Therapeutics, Inc. and TherapeuticsMD, Inc.
Jagi Gill, CEO and Founder of Tenex Health said, “Governor Thompson’s pedigree and expertise is a perfect fit for our company. Our rapid growth has been directly attributed to the clinically compelling results of our technology that improves the lives of patients suffering from joint pain related to tendon injury. As we progress from this strong foundation, the guidance of Governor Thompson and the other members of our Board of Directors will help us strategically and methodically grow our technology’s impact amongst patients and physicians alike.”
About Tenex Health Inc. Tenex Health, Inc. (www.tenexhealth.com) develops and markets innovative therapies for the treatment of tendon pain due to trauma or repetitive motion injuries. These tendon injuries affect more than 10 million persons in the US alone every year. The company’s proprietary TX1 Tissue Removal System is used to safely and specifically cut and debride diseased soft tissue in an outpatient setting using only local anesthetic (www.fast-technique.com). Since the surrounding healthy tendon tissue is not disturbed, patients enjoy less discomfort and faster recovery times versus traditional open surgical procedures. The one-time procedure is usually completed within 20 minutes and with no need for follow-up treatments.